Molbio Diagnostics Limited
Held by 30 mutual fund schemes, ₹1,549Cr between them.
The largest single position is Kotak Mid Cap Fund (Kotak Mahindra), which holds 0.5% of its portfolio in Molbio Diagnostics Limited — ₹373.87Cr, or 24.1% of all the mutual fund money in this stock.
The five largest holders account for 67% of it, across 30 schemes in total.
14 of the 30 largest holdings sit in sectoral/ thematic funds, the most of any category here.
Funds holding Molbio Diagnostics Limited
30Largest rupee position first. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| Kotak Mid Cap Fund | Mid Cap Fund | 0.54% | ₹373.87Cr | ₹69,235Cr |
| HDFC Flexi Cap Fund | Flexi Cap Fund | 0.27% | ₹299.50Cr | ₹1,10,925Cr |
| Kotak Aggressive Hybrid Fund | Aggressive Hybrid Fund | 2.14% | ₹197.14Cr | ₹9,212Cr |
| Kotak Focused Fund | Focused Fund | 2.33% | ₹103.40Cr | ₹4,438Cr |
| Kotak Contra Fund | Contra Fund | 1.30% | ₹69.59Cr | ₹5,353Cr |
| HDFC Pharma and Healthcare Fund | Sectoral/ Thematic | 1.87% | ₹58.49Cr | ₹3,128Cr |
| Mirae Asset Healthcare Fund | Sectoral/ Thematic | 1.69% | ₹58.47Cr | ₹3,458Cr |
| Nippon India Pharma Fund | Sectoral/ Thematic | 0.53% | ₹49.14Cr | ₹9,272Cr |
| Kotak Large Cap Fund | Large Cap Fund | 0.44% | ₹47.36Cr | ₹10,764Cr |
| Mirae Asset Flexi Cap Fund | Flexi Cap Fund | 1.02% | ₹45.01Cr | ₹4,423Cr |
| HDFC Value Fund | Value Fund | 0.53% | ₹42.56Cr | ₹8,030Cr |
| Kotak Healthcare Fund | Sectoral/ Thematic | 4.74% | ₹35.23Cr | ₹743.32Cr |
| Mirae Asset Small Cap Fund | Small Cap Fund | 0.55% | ₹29.87Cr | ₹5,463Cr |
| Kotak Consumption Fund | Sectoral/ Thematic | 1.14% | ₹19.76Cr | ₹1,733Cr |
| ICICI Prudential Exports & Services Fund | Sectoral/ Thematic | 1.00% | ₹14.86Cr | ₹1,484Cr |
| ICICI Prudential Quality Fund | Sectoral/ Thematic | 0.66% | ₹13.94Cr | ₹2,126Cr |
| HDFC Innovation Fund | Sectoral/ Thematic | 0.44% | ₹13.44Cr | ₹3,054Cr |
| Kotak Conservative Hybrid Fund | Conservative Hybrid Fund | 0.36% | ₹10.22Cr | ₹2,839Cr |
| Edelweiss Equity Savings Fund | Equity Savings | 0.61% | ₹9.71Cr | ₹1,592Cr |
| Nippon India Innovation Fund | Sectoral/ Thematic | 0.29% | ₹8.75Cr | ₹3,019Cr |
| Motilal Oswal Large Cap | Large Cap Fund | 0.27% | ₹8.48Cr | ₹3,143Cr |
| PGIM India Large and Midcap Fund | Large & Mid Cap Fund | 1.03% | ₹8.43Cr | ₹818.61Cr |
| Tata India Pharma & Healthcare Fund | Sectoral/ Thematic | 0.53% | ₹8.13Cr | ₹1,534Cr |
| Edelweiss Recently Listed IPO Fund | Sectoral/ Thematic | 0.59% | ₹6.97Cr | ₹1,181Cr |
| HDFC MNC Fund | Sectoral/ Thematic | 0.97% | ₹5.36Cr | ₹552.24Cr |
| WhiteOak Capital Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.95% | ₹4.60Cr | ₹484.23Cr |
| Kotak Multi Asset Allocation Fund | Multi Asset Allocation | 0.03% | ₹4.51Cr | ₹15,048Cr |
| PGIM India Retirement Fund | Retirement Fund | 1.18% | ₹1.26Cr | ₹106.91Cr |
| PGIM India Healthcare Fund | Sectoral/ Thematic | 0.72% | ₹85.14L | ₹118.25Cr |
| WhiteOak Capital Pharma and Healthcare Fund | Sectoral/ Thematic | 1.15% | — | — |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 29 of the 30 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Funds buying and selling Molbio Diagnostics Limited
In their latest monthly disclosure, 3 funds bought and 3 sold, judged by share count.
| Fund | Move | Weight | Value |
|---|---|---|---|
| Kotak Focused Fund | Added | 0.18% → 2.33% | ₹91.09Cr |
| Nippon India Innovation Fund | Cut | 0.73% → 0.29% | -₹12.74Cr |
| Mirae Asset Small Cap Fund | Added | 0.30% → 0.55% | ₹11.13Cr |
| WhiteOak Capital Multi Asset Allocation Fund | Exited | 0.04% → — | -₹3.39Cr |
| Kotak Large Cap Fund | Added | 0.43% → 0.44% | ₹2.55Cr |
| WhiteOak Capital Balanced Advantage Fund | Exited | 0.01% → — | -₹30.63L |
Frequently asked questions
Which mutual fund holds the most Molbio Diagnostics Limited?
By rupee value, Kotak Mid Cap Fund from Kotak Mahindra — ₹373.87Cr, at 0.5% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in Molbio Diagnostics Limited?
Kotak Healthcare Fund carries the largest weight at 4.7% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold Molbio Diagnostics Limited?
30 schemes, holding ₹1,549Cr between them across the 29 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Molbio Diagnostics Limited make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.